Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development.

Ubah OC, Steven J, Kovaleva M, Ferguson L, Barelle C, Porter AJR, Barelle CJ.

Front Immunol. 2017 Dec 22;8:1780. doi: 10.3389/fimmu.2017.01780. eCollection 2017.

2.

Impact of Omega-3 Fatty Acids on the Gut Microbiota.

Costantini L, Molinari R, Farinon B, Merendino N.

Int J Mol Sci. 2017 Dec 7;18(12). pii: E2645. doi: 10.3390/ijms18122645. Review.

3.

Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease.

Cukrowska B, Sowińska A, Bierła JB, Czarnowska E, Rybak A, Grzybowska-Chlebowczyk U.

World J Gastroenterol. 2017 Nov 14;23(42):7505-7518. doi: 10.3748/wjg.v23.i42.7505. Review.

4.

Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis.

Stadlbauer V, Horvath A, Ribitsch W, Schmerböck B, Schilcher G, Lemesch S, Stiegler P, Rosenkranz AR, Fickert P, Leber B.

Sci Rep. 2017 Nov 15;7(1):15601. doi: 10.1038/s41598-017-15650-9.

5.

Fecal zonulin is elevated in Crohn's disease and in cigarette smokers.

Malíčková K, Francová I, Lukáš M, Kolář M, Králíková E, Bortlík M, Ďuricová D, Štěpánková L, Zvolská K, Pánková A, Zima T.

Pract Lab Med. 2017 Sep 23;9:39-44. doi: 10.1016/j.plabm.2017.09.001. eCollection 2017 Dec.

6.

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.

Pierantonelli I, Rychlicki C, Agostinelli L, Giordano DM, Gaggini M, Fraumene C, Saponaro C, Manghina V, Sartini L, Mingarelli E, Pinto C, Buzzigoli E, Trozzi L, Giordano A, Marzioni M, De Minicis S, Uzzau S, Cinti S, Gastalderi A, Svegliati-Baroni G.

Sci Rep. 2017 Sep 22;7(1):12200. doi: 10.1038/s41598-017-11744-6. Erratum in: Sci Rep. 2017 Dec 11;7(1):17568.

7.

Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women.

Ott B, Skurk T, Hastreiter L, Lagkouvardos I, Fischer S, Büttner J, Kellerer T, Clavel T, Rychlik M, Haller D, Hauner H.

Sci Rep. 2017 Sep 20;7(1):11955. doi: 10.1038/s41598-017-12109-9.

8.

Fluctuation of zonulin levels in blood vs stability of antibodies.

Vojdani A, Vojdani E, Kharrazian D.

World J Gastroenterol. 2017 Aug 21;23(31):5669-5679. doi: 10.3748/wjg.v23.i31.5669.

9.

Zonulin: A Potential Marker of Intestine Injury in Newborns.

Tarko A, Suchojad A, Michalec M, Majcherczyk M, Brzozowska A, Maruniak-Chudek I.

Dis Markers. 2017;2017:2413437. doi: 10.1155/2017/2413437. Epub 2017 Jul 9.

10.

Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia.

Sarker P, Banik A, Stromberg R, Gudmundsson GH, Raqib R, Agerberth B.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02570-16. doi: 10.1128/AAC.02570-16. Print 2017 Jul.

11.

Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model.

Sturgeon C, Lan J, Fasano A.

Ann N Y Acad Sci. 2017 Jun;1397(1):130-142. doi: 10.1111/nyas.13343. Epub 2017 Apr 19.

PMID:
28423466
12.

Regulation of intestinal permeability: The role of proteases.

Van Spaendonk H, Ceuleers H, Witters L, Patteet E, Joossens J, Augustyns K, Lambeir AM, De Meester I, De Man JG, De Winter BY.

World J Gastroenterol. 2017 Mar 28;23(12):2106-2123. doi: 10.3748/wjg.v23.i12.2106. Review.

13.

Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Sturgeon C, Fasano A.

Tissue Barriers. 2016 Oct 21;4(4):e1251384. doi: 10.1080/21688370.2016.1251384. eCollection 2016. Review.

14.

Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, D-lactate and markers of inflammation in haemodialysis patients.

Ficek J, Wyskida K, Ficek R, Wajda J, Klein D, Witkowicz J, Rotkegel S, Spiechowicz-Zatoń U, Kocemba-Dyczek J, Ciepał J, Więcek A, Olszanecka-Glinianowicz M, Chudek J.

Int Urol Nephrol. 2017 Apr;49(4):717-725. doi: 10.1007/s11255-016-1495-5. Epub 2017 Jan 2.

15.

Coeliac disease: a unique model for investigating broken tolerance in autoimmunity.

Hardy MY, Tye-Din JA.

Clin Transl Immunology. 2016 Nov 2;5(11):e112. eCollection 2016 Nov. Review.

16.

The intestinal epithelial barrier: a therapeutic target?

Odenwald MA, Turner JR.

Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21. doi: 10.1038/nrgastro.2016.169. Epub 2016 Nov 16. Review.

17.

Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.

Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, Lähdeaho ML, Linros J, Apter D, Scheinin M, Kloster Smerud H, Rissanen A, Lahtinen S.

EBioMedicine. 2016 Nov;13:190-200. doi: 10.1016/j.ebiom.2016.10.036. Epub 2016 Oct 26.

18.

A role for intestinal TLR4-driven inflammatory response during activity-based anorexia.

Belmonte L, Achamrah N, Nobis S, Guérin C, Riou G, Bôle-Feysot C, Boyer O, Richard V, Rego JC, Déchelotte P, Goichon A, Coëffier M.

Sci Rep. 2016 Oct 25;6:35813. doi: 10.1038/srep35813.

19.

Human Intestinal Barrier Function in Health and Disease.

König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer RJ.

Clin Transl Gastroenterol. 2016 Oct 20;7(10):e196. doi: 10.1038/ctg.2016.54. Review.

20.

Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.

Ling X, Linglong P, Weixia D, Hong W.

PLoS One. 2016 Aug 23;11(8):e0161635. doi: 10.1371/journal.pone.0161635. eCollection 2016.

Supplemental Content

Support Center